Testing spinal cord stimulation for chronic pain relief
Official title: Effects of Spinal Cord Stimulation
Run by University of Aarhus · NCT05885061 · Data updated 2026-11-12
This study tests whether turning spinal cord stimulation on or off can help people with chronic pain feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | University of Aarhus Academic / other |
| Locations | 1 site (Aarhus) |
| Status | Recruiting |
| Started | January 2, 2025 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | April 1, 2026 |
| Trial ID | NCT05885061 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old who have had spinal cord stimulation implanted for chronic pain for at least six months.
✕Probably not a fit
Patients currently receiving other neuromodulation treatments or who have recently changed their pain medication may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study aims to evaluate the effects of spinal cord stimulation (SCS) on patients suffering from chronic pain. Participants will compare their pain levels while using SCS turned on versus turned off, allowing researchers to assess the effectiveness of the treatment. The study focuses on patients who have had SCS implanted for at least six months and are currently experiencing chronic pain. By measuring pain scores, the study seeks to determine the true impact of SCS on pain management.
Why it matters
Potential benefit: If successful, this study could provide a more effective pain management option for patients with chronic pain.
How similar studies have gone: Previous studies on spinal cord stimulation have shown promising results, indicating that this approach is not entirely novel but continues to be explored for its efficacy.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients (\>18 years of age) with SCS implanted to treat chronic pain. * Patients who consent to participation and can cooperate in the study. * Use of continuous paresthesia-free SCS for minimum 6 months prior to participation in the study. * Pain score of 7 or less on a 0-10 scale in the most painful area treated with SCS, rated upon inclusion. * Patients not receiving other neuromodulation treatment. * Patients who have not undergone changes in their (pain relevant) medication during the last 30 days (pro necessitate medication allowed).
Where it's running
-
Department of Neurosurgery, Aarhus University Hospital
Aarhus, Denmark Recruiting
Study contacts
- Study coordinator: Lene Vase
- Email: lenevase@psy.au.dk
- Phone: +4587165828
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital
A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.
-
Meaning-Based Psychotherapy for Adults with Chronic Pain
This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.
-
How chronic pain changes over time in kids with Duchenne Muscular Dystrophy
This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.
-
CBD for Opioid Dependence and Pain on Buprenorphine
This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.
-
Cebranopadol for opioid withdrawal in adults with chronic pain
This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.